164 related articles for article (PubMed ID: 20647645)
1. Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008.
Fukushima Y; Fukushima F; Kamiya K; Hayashi Y; Tatewaki M; Yamada I; Hirata H; Sugiyama K; Ishii Y; Fukuda T
Intern Med; 2010; 49(14):1333-40. PubMed ID: 20647645
[TBL] [Abstract][Full Text] [Related]
2. A new carbapenem drug dosage metric for carbapenem usage and correlation with carbapenem resistance of Pseudomonas aeruginosa.
Hirayama S; Yasui K; Murakami H; Kosugi T; Sakamoto M; Hanai Y; Matsuo K; Miyazaki T; Ishii Y; Nishizawa K; Tateda K
J Infect Chemother; 2018 Dec; 24(12):949-953. PubMed ID: 30268412
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of antimicrobial agents against clinical isolates of Pseudomonas aeruginosa].
Abe N; Komatsu M; Iwasaki M; Nagasaka Y; Fukuda S; Matsuo S; Shimakawa K
Jpn J Antibiot; 2005 Oct; 58(5):445-51. PubMed ID: 16379156
[TBL] [Abstract][Full Text] [Related]
4. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
[TBL] [Abstract][Full Text] [Related]
5. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa.
Chen HY; Yuan M; Ibrahim-Elmagboul IB; Livermore DM
J Antimicrob Chemother; 1995 Apr; 35(4):521-34. PubMed ID: 7628986
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa: Evaluation of Pathogen Burden and Drug-Resistance Trends in a Tertiary Care Hospital.
Saeed M; Rasheed F; Afzal RK; Hussain S; Riaz S; Ahmad A
J Coll Physicians Surg Pak; 2018 Apr; 28(4):279-283. PubMed ID: 29615167
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents.
Fujimura T; Anan N; Sugimori G; Watanabe T; Jinushi Y; Yoshida I; Yamano Y
Int J Antimicrob Agents; 2009 Dec; 34(6):523-8. PubMed ID: 19748767
[TBL] [Abstract][Full Text] [Related]
8. Survey of antibiotic resistance in Pseudomonas aeruginosa by The Tokyo Johoku Association of Pseudomonas Studies.
Kato K; Iwai S; Kumasaka K; Horikoshi A; Inada S; Inamatsu T; Ono Y; Nishiya H; Hanatani Y; Narita T; Sekino H; Hayashi I;
J Infect Chemother; 2001 Dec; 7(4):258-62. PubMed ID: 11810595
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on the effective dosage regimens for meropenem, biapenem and doripenem against P. aeruginosa infection based on pharmacokinetics and pharmacodynamics theory].
Sumitani Y; Kobayashi Y
Jpn J Antibiot; 2007 Dec; 60(6):394-403. PubMed ID: 18447209
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
[TBL] [Abstract][Full Text] [Related]
11. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance of Pseudomonas aeruginosa strains isolated from surgical infections in a 7-year period at a general hospital in Venezuela.
Rodriguez CN; Rodriguez-Morales AJ; Garcia A; Pastran B; Meijomil P
Surg Infect (Larchmt); 2006 Jun; 7(3):269-73. PubMed ID: 16875460
[TBL] [Abstract][Full Text] [Related]
13. [The annual changes in antimicrobial susceptibility test results of Pseudomonas aeruginosa isolates from the Kinki district].
Fukuda S; Komatsu M; Nakamura T; Jikimoto T; Nishio H; Yamasaki K; Satoh K; Toda H; Orita T; Sueyoshi N; Kita M; Nishi I; Akagi M; Higuchi T; Kofuku T; Nakai I; Ono T; Kida K; Ohama M; Watari H; Shimura S; Niki M; Kuchibiro T; Wada Y
Jpn J Antibiot; 2016 Apr; 69(2):101-10. PubMed ID: 27544978
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
Sader HS; Huband MD; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
[No Abstract] [Full Text] [Related]
15. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter surveillance of Pseudomonas aeruginosa strains for antimicrobials in Aichi prefecture in 2009].
Iguchi M; Mochizuki M; Yagi T; Ookawa H; Shimazaki Y; Ootsuka Y; Sato K; Shiota A; Wakiyama N; Nakamura A; Kidono M; Hara Y; Asai S; Kawashima M; Sakuragi K; Asahi J; Murase H; Nishio M; Miyaki Y; Funahashi K; Mouri T; Sugiura Y; Yamada T; Kondo K; Sahara K; Sugaki Y; Kawabata A; Itou Y; Yamamoto Y; Kinoshita K; Yamaguchi I; Sasano M; Inukai T; Matsui N; Kuramae H; Okugawa M; Kawai H; Shibata M; Inuzuka K; Yamada A; Koita I; Suematsu H; Sawamura H; Yamagishi Y; Mikamo H;
Jpn J Antibiot; 2013 Aug; 66(4):211-25. PubMed ID: 24396982
[TBL] [Abstract][Full Text] [Related]
17. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Ogbolu DO; Ogunledun A; Adebiyi OE; Daini OA; Alli AO
Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of carbapenem-resistant Pseudomonas aeruginosa strains in patients with ventilator-associated pneumonia in intensive care units.
Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Bakšytė G; Macas A; Sakalauskas R
Medicina (Kaunas); 2011; 47(12):652-6. PubMed ID: 22370463
[TBL] [Abstract][Full Text] [Related]
20. [Changes of drug-resistance of Pseudomonas aeruginosa in pediatric intensive care unit].
Wang LJ; Sun Y; Song WL; Zhang ZJ; Liu CF
Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):657-63. PubMed ID: 23158814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
